Rumana Rafiq
Publications by Year
Research Areas
Chromatin Remodeling and Cancer, PARP inhibition in cancer therapy, Cancer Mechanisms and Therapy, Animal Virus Infections Studies, Ovarian cancer diagnosis and treatment
Most-Cited Works
- → Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance(2018)438 cited
- → ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A(2016)379 cited
- → Genome-wide Profiling of Genetic Synthetic Lethality Identifies CDK12 as a Novel Determinant of PARP1/2 Inhibitor Sensitivity(2013)363 cited
- → Functional Viability Profiles of Breast Cancer(2011)142 cited
- → E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast Cancer(2018)129 cited
- → Large-Scale Profiling of Kinase Dependencies in Cancer Cell Lines(2016)108 cited
- → Proteomic analysis of increased Parkin expression and its interactants provides evidence for a role in modulation of mitochondrial function(2009)87 cited
- → Modeling Therapy Resistance in BRCA1/2 -Mutant Cancers(2017)86 cited
- → Synthetic Lethal Targeting of ARID1A -Mutant Ovarian Clear Cell Tumors with Dasatinib(2016)84 cited
- → A novel tankyrase inhibitor, MSC2504877, enhances the effects of clinical CDK4/6 inhibitors(2019)59 cited